---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-053564"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2025-05-28T23:59:59+00:00"
generated_at: "2026-05-20T09:14:31.741368+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics CFO David Patience resigns effective June 30, 2025

## Summary
- David Patience notified Board on May 21, 2025; resignation effective June 30, 2025.
- He served as principal financial and accounting officer; no replacement announced.
- Resignation is for other professional opportunities, not due to any disagreement with the company.

## SEC filing metadata
- accession: 0001104659-25-053564
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2025-05-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465925053564/0001104659-25-053564-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465925053564/tm2516297d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-053564
- JSON: https://secwatch.observer/filing/0001104659-25-053564.json
- Plain text: https://secwatch.observer/filing/0001104659-25-053564.txt

## Key facts
- Executive change
  David Patience resigned as Chief Financial Officer at Accelerate Diagnostics, Inc.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On May 21, 2025, David Patience notified the Board of Directors of Accelerate Diagnostics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective June 30, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465925053564/0001104659-25-053564-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.